Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2Unknown 1Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 6Oropharyngeal Neoplasms 5Uterine Cervical Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Hypopharyngeal Neoplasms 3Radiation Injuries 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Laryngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Sinonasal Squamous Cell Carcinoma 1Rectal Malignant Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ototoxicity 1Neoplasms 1Myelosuppression 1Mouth Neoplasms 1Margins of Excision 1Malignant Tumor of Lacrimal Drainage Structure 1Low Anterior Resection Syndrome 1Locally Advanced Hypopharyngeal Carcinoma 1

Interventions

Cisplatin 20Radiotherapy 16Paclitaxel 14Carboplatin 12pembrolizumab 11Drug Therapy 11tislelizumab 10Fluorouracil 8Neoadjuvant Therapy 7130-nm albumin-bound paclitaxel 7sintilimab 5Esophagectomy 5toripalimab 4Tegafur 4TP protocol 4Nivolumab 4Irinotecan 4Immunotherapy 4spartalizumab 3S 1 (combination) 3Oxaliplatin 3Leucovorin 3Itraconazole 3Docetaxel 3Albumin-Bound Paclitaxel 3nimotuzumab 2apatinib 2Taxes 2Radiotherapy, Intensity-Modulated 2Immune Checkpoint Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Esophageal Squamous Cell Carcinoma × Chemoradiotherapy × Clear all
NCT06452602 2026-02-27

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04328948 2025-05-22

ARMADILLO

National Cancer Center, Japan

Phase 3 Recruiting
280 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡